Clinical Trial Update: Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 post-marketing trial to re-evaluate WangBi Granules for rheumatoid arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• WangBi Granules

Snippet

Sponsor: China-Japan Friendship Hospital | Conditions: Rheumatoid Arthritis | Phase 4 | Status: RECRUITING